This Thematic Network brings together IBEC researchers to explore cutting-edge developments in various aspects of the central nervous system (CNS), ranging from basic research to innovative therapeutic strategies. This network … Read more
Rare diseases are a diverse group of disorders with low prevalence, but if we combined all patients, they would form the world’s 3rd largest population. These diseases pose significant challenges … Read more
Beyond NGS: A toolbox for single-molecule epigenetic analysis of DNA Prof. Yuval Ebenstein, Department of Physical Chemistry, Department of Biomedical Engineering, Founder, Innovation and Entrepreneurship Center Tel Aviv University, Israel. … Read more
For the seventh consecutive year, IBEC, with the support of the Catalunya La Pedrera Foundation, has successfully run its ‘Mad for Bioengineering’ course. Aimed at first-year students interested in STEM careers, the programme offers a unique immersion into the world of bioengineering, tackling health problems from a multidisciplinary perspective. The closing ceremony, attended by the students and their families, focused on the presentation of the final projects and the awarding of diplomas.
IBEC’s Principal Investigator César Rodriguez-Emmenegger has been awarded an ERC Consolidator Grant. This prestigious European funding supports scientists in the consolidation phase of their research teams, allowing them to pursue innovative scientific ideas. The €2 million over five years will allow Rodriguez-Emmenegger and his team to develop Phagocytic Synthetic Cells (PSCs) to fight antibiotic-resistant pathogens.
La start-up catalana Nanobots Therapeutics, una spin-off del Instituto de Bioingeniería de Catalunya, ha captado 960.000 euros de capital privado.
